Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christine Norris"'
Publikováno v:
Journal of Management History, 2000, Vol. 6, Issue 3, pp. 113-126.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/EUM0000000005329
Autor:
Maya Gurnani, Nicholas Bauman, Cara A. Mendrick, R. Jason Herr, Paul M. McNicholas, Nathaniel Brown, Barry Antonacci, Anthony Cacciapuoti, Samuel Wainhaus, Andrew S. Chau, Michelle F. Waldman, Todd A. Black, Paul Mann, Christine Norris, Rongze Kuang, Ilias Triantafyllou, Pauline C. Ting, Yiming Xu, Robert G. Aslanian, Scott S. Walker, Reena Patel
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:5099-5106
The echinocandins are a class of semisynthetic natural products that target β-1,3-glucan synthase (GS). Their proven clinical efficacy combined with minimal safety issues has made the echinocandins an important asset in the management of fungal infe
Publikováno v:
Journal of Management History. 6:113-126
Over the past 100 years, the interview has received much attention. It is generally agreed that the interview is modest in terms of reliability or validity. In spite of this, it will continue to be used as a selection tool. Research has shown that st
Autor:
Christine Norris, John Dattilo
Publikováno v:
Focus on Autism and Other Developmental Disabilities. 14:180-186
There has been little evaluation of the effectiveness of social stories. The purpose of this study was to examine the effects of a social story intervention on the social behaviors of an 8-year-old girl with autism who attended an inclusive second-gr
Autor:
Christine Norris, Taisa Yarosh-Tomaine, David Loebenberg, Imtiaz A. Chaudry, Seb Assenza, B Antonacci, Lorraine Wearley, Nancy Levine, Charles G. Eckhart, Joel A. Sequeira, R. Parmegiani, Anthony Cacciapuoti
Publikováno v:
Pharmaceutical Research. 10:136-140
The topical antifungal Sch-39304 is a racemic compound comprised of two enantiomers, Sch-42427 and Sch-42426, only one of which (Sch-42427) is pharmacologically active. The pure enantiomers have a lower melting point and, therefore, a higher solubili
Autor:
Raulo Parmegiani, B Antonacci, F. Menzel, George H. Miller, Taisa Yarosh-Tomaine, Anthony Cacciapuoti, Christine Norris, David Loebenberg, L. Moss, Roberta S. Hare
Publikováno v:
Medical Mycology. 31:239-248
Sch 39304 is a new broad spectrum triazole antifungal agent that is active, orally and topically, against superficial Trichophyton mentagrophytes and vaginal Candida albicans infections. Sch 39304 was compared to fluconazole (FLZ) in a T. mentagrophy
Autor:
Christine Norris, David Loebenberg, Raulo Parmegiani, Taisa Yarosh-Tomaine, F. Menzel, Roberta S. Hare, George H. Miller, B Antonacci, Eugene L. Moss, Anthony Cacciapuoti
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:498-501
SCH 39304, a new triazole antifungal agent, is a 50:50 racemic mixture of two enantiomers, SCH 42427 and SCH 42426. The activities of these three compounds were compared in a series of in vitro and in vivo experiments. SCH 42427 was twofold more acti
Autor:
Christine Norris
Publikováno v:
Phenomenology + Pedagogy. :237-244
Autor:
Cara Mendrick, Christine Norris, David Loebenberg, Todd A. Black, F J Sabatelli, Reena Patel, Paul A. Mann, Roberta S. Hare, Paul M. McNicholas
Publikováno v:
Antimicrobial agents and chemotherapy. 50(6)
The in vitro activity of the novel triazole antifungal agent posaconazole (Noxafil; SCH 56592) was assessed in 45 laboratories against approximately 19,000 clinically important strains of yeasts and molds. The activity of posaconazole was compared wi
Autor:
S. Subbanna, Huilong Zhu, T. Shinohara, R.-V. Bentum, H. Kuroda, C. Penny, Jay W. Strane, D. McHerron, D. Harmon, D. Zamdmer, Q. Ye, Yoshiaki Toyoshima, Paul D. Agnello, S. Wu, G. Freeman, L. Tsou, Atsushi Azuma, Scott J. Bukofsky, Carl J. Radens, M. Angyal, M. Fukasawa, Effendi Leobandung, Byeong Y. Kim, M. Gerhardt, Y. Tan, L. Su, Tenko Yamashita, Anda Mocuta, I.C. Inouc, Takeshi Nogami, Scott D. Allen, R. Logan, K. Miyamoto, Shih-Fen Huang, Ravikumar Ramachandran, J. Pellerin, A. Ray, Siddhartha Panda, Christine Norris, H.V. Meer, H. Nayakama, Mizuki Ono, Keith Jenkins, J. Heaps-Nelson, Wenjuan Zhu, D. Ryan, Michael A. Gribelyuk, B. Dirahoui, M. Inohara, E. Nowak, I. Melville, S. Lane, T. Ivers, K. Ida, Scott Halle, Ishtiaq Ahsan, M.-F. Ng, Huicai Zhong, H. Harifuchi, S.-K. Ku, N. Kepler, F. Wirbeleit, Emmanuel F. Crabbe, H. Yan, T. Kawamura, Mahender Kumar, A. Nomura, L. K. Wang, F. Sugaya, H. Hichri, Gary B. Bronner, P. O'Neil, K. Miyashita, Michael P. Belyansky, J. Cheng, S.-H. Rhee, Lars W. Liebmann, D. Yoneyama, Dan Mocuta, K. McStay, G. Sudo, Dureseti Chidambarrao
Publikováno v:
Digest of Technical Papers. 2005 Symposium on VLSI Technology, 2005..
A high performance 65 nm SOI CMOS technology is presented featuring 35 nm gate length, 1.05 nm gate oxide, performance enhancement from dual stress nitride liners (DSL), and 10 wiring levels with low-k dielectric offered in the first 8 levels. DSL en